ZOLL Lifecor
About the LifeVest Benefits About SCA What is SCA Treating SCA Patient Stories FAQs Press and Events Image Library About ZOLL Lifecor Contact Us Home
Treating SCA

Treating Sudden Cardiac Arrest (SCA)
The only definitive treatment to terminate ventricular fibrillation is defibrillation, the application of an electric shock to the heart using a defibrillator. Successful termination of ventricular fibrillation by defibrillation enables the heart to resume a coordinated normal rhythm. If applied quickly after the onset of SCA, defibrillation can be highly effective. Although cardiopulmonary resuscitation (CPR) can be performed in the event of SCA, it does not terminate ventricular fibrillation and is only useful to sustain life for several minutes until defibrillation can be administered.

Chances of Survival
Timely defibrillation is the single most important factor in saving the SCA victim's life. The sooner defibrillation therapy can be performed, the higher the likelihood of survival. In expensive hospital environments, external defibrillation is frequently successful because the patient is continuously monitored and trained hospital personnel are readily available to apply the shock. Otherwise, successful defibrillation depends on the SCA victim being observed and on the arrival of emergency medical personnel. Since most SCA events are not witnessed and response times average greater than ten minutes outside the hospital, the survival rate of SCA victims in the United States is typically less than 10%.

1. Nichol et al., “A Cumulative Meta-Analysis of the Effectiveness of Defibrillator-Capable Emergency Medical Services for Victims of Out-of-Hospital Cardiac Arrest,” Annals of Emergency Medicine, October 1999, pp.517-525.

2. Thel and O’Connor, “Cardiopulmonary Resuscitation: Historical Perspective to Recent Investigations,” American Heart Journal, January 1999, pp. 39-48.

3. Feldman, et al., "New Therapeutic Option for Patients with Time-Dependent Risk of Sudden Cardiac Arrest: Application of Novel Wearable Cardioverter-Defibrillator," Abstract of presenta-tion made by Dr. Arthur Feldman at American College of Cardiology Meeting, March 18, 2002, Atlanta, Georgia.